Skip to main
HLF

Herbalife (HLF) Stock Forecast & Price Target

Herbalife (HLF) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Herbalife is well-positioned for growth, with a strong product portfolio and a direct-selling business model that has proven successful in 95 markets. Despite industry headwinds, the company continues to execute on strategic initiatives (such as distribution expansion and innovation) and has shown resilience in volume growth. Margins are also expected to improve in the near-term, leading to a positive outlook for future adjusted EBITDA growth and potential share price appreciation. However, potential risks such as economic recessions and supply disruptions should be closely monitored.

Bears say

Herbalife is facing significant headwinds due to elevated promotional activity and higher input costs, as well as risks associated with acquisitions and economic recession. While the company is making efforts to support sales and innovation, the current operating environment remains challenging and visibility on potential catalysts is limited. As a result, it is advisable to remain on the sidelines until there is greater clarity on the company's EBITDA outlook and sustainability issues.

Herbalife (HLF) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Herbalife and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Herbalife (HLF) Forecast

Analysts have given Herbalife (HLF) a Buy based on their latest research and market trends.

According to 4 analysts, Herbalife (HLF) has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Herbalife (HLF)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.